Sagility Limited has announced the scheduling of its Investor & Analyst Day for March 25, 2026 in Mumbai, as communicated to stock exchanges on March 13, 2026. The event represents a key engagement initiative between the company and the investment community.

Event Details and Format

The investor meeting has been structured as an in-person group session, scheduled to commence from 1:30 p.m. onwards on March 25, 2026 in Mumbai. The company has made registration facilities available through a dedicated link on its corporate website.

Regulatory Compliance

The announcement has been made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sagility Limited has specifically clarified that no unpublished price sensitive information is proposed to be shared during the event, ensuring compliance with disclosure norms.

Flexibility and Access

The company has indicated that dates and timings remain subject to potential changes due to exigencies on the part of investors or the company. Complete event details are being made available on the company's website at www.sagilityhealth.com , providing stakeholders with accessible information regarding the investor engagement.

The communication was signed by Satishkumar Sakharayapattana Seetharamaiah, Company Secretary & Compliance Officer, and submitted to both NSE and BSE as part of the company's listing obligations.

Sagility Limited delivered exceptional financial performance for the quarter ended December 31, 2025, demonstrating strong growth across key metrics. The healthcare business process management services provider reported consolidated revenue of ₹19,712 million, representing a significant 35.7% year-on-year increase, with organic growth contributing 19.9% to this expansion.

Financial Performance Highlights

The company's financial metrics showcased robust operational efficiency and growth momentum across multiple parameters:

For the nine-month period ended December 31, 2025, Sagility maintained strong performance with revenue at ₹51,686 million, up 29.2% year-on-year. Adjusted EBITDA for the nine-month period reached ₹13,164 million at 25.5% margin, while adjusted PAT grew 44.3% to ₹8,236 million.

Strategic Acquisition and Business Expansion

Sagility completed a significant strategic acquisition during the period, purchasing 100% of BroadPath through its subsidiary Sagility LLC for USD 55.69 million. The acquisition details include:

BroadPath is a US healthcare solutions provider serving mid-market payer clients with services including member engagement, claims administration, and provider credentialing. This acquisition expands Sagility's exposure to open-enrollment-driven work and broadens its payer client base.

Operational Metrics and Market Position

Sagility's operational scale continued to expand with the company employing 48,522 people at the end of Q3FY26, representing a 22.5% increase from 39,595 employees in Q3FY25. The company maintains a global presence across 5 countries with 35 delivery centers.

Revenue distribution by vertical showed strong performance across both segments:

Management Commentary and Earnings Webinar Insights

During the earnings webinar held on January 28, 2026, Managing Director and Group CEO Ramesh Gopalan highlighted the exceptional quarter performance, particularly noting successful outcomes during the open enrollment period across large payer relationships. He emphasized the company's strong position as clients navigate evolving regulatory environments with increasing focus on outcome-oriented delivery models and cost reduction initiatives.

Gopalan outlined three strategic pillars for long-term growth: expanding into white spaces within existing accounts, building large transformation-led and outcome-based managed services constructs, and accelerating expansion into the middle and small market segments. The company successfully deployed 32 distinct AI-driven use cases across 10 clients during the quarter.

Deputy Chief Financial Officer Abhishek Kayan noted the company's ability to scale rapidly while maintaining financial discipline, delivering strong revenue growth without compromising margins through operational excellence and robust cost management.

Revised Guidance and Future Outlook

Based on the better-than-expected open enrollment season performance, Sagility raised its FY26 revenue guidance to 22.5% growth in constant currency terms, including organic growth of 13.8%. The company maintained its adjusted EBITDA margin guidance at 25% for the full fiscal year.

The company won business from 22 existing clients and added three new clients during Q3, with aggregate annual contract value of USD 30.5 million. New client wins included a top 10 health insurance company, a benefit administration company, and a regional health insurance plan.

Exceptional Items and Regulatory Impact

The company reported an exceptional item of ₹328.23 million related to the impact of new Labour Codes notified by the Government of India on November 21, 2025. These codes consolidate 29 existing labour laws and prescribe uniform wage definitions affecting employee benefits calculations including gratuity, leave encashment, and provident fund contributions.